Anti-AMHRII humanised monoclonal antibody (GamaMabs Pharma)

N/A

Report date: 2024/02/05 13:54:06

Base Information

Drug NameAnti-AMHRII humanised monoclonal antibody (GamaMabs Pharma)

Drug Alias NameHumanised monoclonal antibody 12G4hmAb-12G4GM-103

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionAnti-Mullerian hormone receptor II antagonists

TargetsAnti-Mullerian hormone receptor II

Therapy Area/IndicationsOvarian Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesGamamabs Pharma

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGamamabs Pharma

Active IndicationsN/A

Inactive IndicationsOvarian Neoplasms

Other Information

ATC CodeN/A